This announcement is a separate document:
賽生藥業：新百利融資有限公司代表賽生藥業控股有限公司提出有條件現金要約按每股股份10.06港元回購最多達77,534,791股股份及申請清洗豁免股東特別大會投票表決結果
SCICLONE PHARMA: CONDITIONAL CASH OFFER BY SOMERLEY CAPITAL LIMITED ON BEHALF OF SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED TO BUY-BACK UP TO 77,534,791 SHARES AT HK$10.06 PER SHARE AND APPLICATION FOR WHITEWASH WAIVER POLL RESULTS OF THE EXTRAORDINARY GE
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.